Published in J Gastroenterol Hepatol on July 01, 2007
High molecular weight polyethylene glycol (PEG 15-20) maintains mucosal microbial barrier function during intestinal graft preservation. J Surg Res (2013) 1.51
High-molecular-weight polyethylene glycol inhibits myocardial ischemia-reperfusion injury in vivo. J Thorac Cardiovasc Surg (2014) 1.40
Organ Preservation: Current Concepts and New Strategies for the Next Decade. Transfus Med Hemother (2011) 0.98
IGL-1 solution reduces endoplasmic reticulum stress and apoptosis in rat liver transplantation. Cell Death Dis (2012) 0.93
Insulin like growth factor-1 increases fatty liver preservation in IGL-1 solution. World J Gastroenterol (2010) 0.84
Polyethylene glycol rinse solution: an effective way to prevent ischemia-reperfusion injury. World J Gastroenterol (2014) 0.83
Multidrug donor preconditioning prevents cold liver preservation and reperfusion injury. Langenbecks Arch Surg (2010) 0.81
Preservation of non-heart-beating donor livers in extracorporeal liver perfusion and histidine-trytophan-ketoglutarate solution. World J Gastroenterol (2008) 0.77
Modifications to the UW: simple solutions to the 'sticky' problem of preservation injury in liver transplantation. J Gastroenterol Hepatol (2007) 0.75
GSK3β and VDAC Involvement in ER Stress and Apoptosis Modulation during Orthotopic Liver Transplantation. Int J Mol Sci (2017) 0.75
Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis. J Hepatol (2002) 1.69
Preconditioning protects liver and lung damage in rat liver transplantation: role of xanthine/xanthine oxidase. Hepatology (2002) 1.54
Protection against lung damage in reduced-size liver transplantation. Crit Care Med (2006) 1.43
Carbonic Anhydrase Protects Fatty Liver Grafts against Ischemic Reperfusion Damage. PLoS One (2015) 1.36
Ischemic preconditioning increases the tolerance of Fatty liver to hepatic ischemia-reperfusion injury in the rat. Am J Pathol (2002) 1.32
Neurodegeneration and functional impairments associated with glycogen synthase accumulation in a mouse model of Lafora disease. EMBO Mol Med (2011) 1.24
Microvascular dysfunction induced by reperfusion injury and protective effect of ischemic preconditioning. Free Radic Biol Med (2002) 1.15
Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion. Hepatology (2004) 1.11
Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. Life Sci (2006) 1.08
Association of arterial rigidity with incident kidney disease and kidney function decline: the Health ABC study. Clin J Am Soc Nephrol (2012) 1.02
Intestinal mucosal oxidative damage and bacterial translocation in cirrhotic rats. Eur J Gastroenterol Hepatol (2003) 0.99
Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with CKD. Am J Kidney Dis (2006) 0.99
AMPK involvement in endoplasmic reticulum stress and autophagy modulation after fatty liver graft preservation: a role for melatonin and trimetazidine cocktail. J Pineal Res (2013) 0.98
Hypoxia inducible factor-1alpha accumulation in steatotic liver preservation: role of nitric oxide. World J Gastroenterol (2010) 0.97
Nitric oxide in ascitic fluid is an independent predictor of the development of renal impairment in patients with cirrhosis and spontaneous bacterial peritonitis. Eur J Gastroenterol Hepatol (2004) 0.97
Addition of adenosine monophosphate-activated protein kinase activators to University of Wisconsin solution: a way of protecting rat steatotic livers. Liver Transpl (2007) 0.96
Preservation of steatotic livers in IGL-1 solution. Liver Transpl (2006) 0.95
Pharmacological strategies against cold ischemia reperfusion injury. Expert Opin Pharmacother (2010) 0.92
Heat shock proteins and mitogen-activated protein kinases in steatotic livers undergoing ischemia-reperfusion: some answers. Am J Pathol (2006) 0.92
Adenosine monophosphate-activated protein kinase and nitric oxide in rat steatotic liver transplantation. J Hepatol (2005) 0.91
Hepatic microcirculatory failure. Acta Cir Bras (2006) 0.90
Is ischemic preconditioning a useful strategy in steatotic liver transplantation? Am J Transplant (2004) 0.89
Are angiotensin II receptor antagonists useful strategies in steatotic and nonsteatotic livers in conditions of partial hepatectomy under ischemia-reperfusion? J Pharmacol Exp Ther (2008) 0.89
Activation of peroxisome proliferator-activated receptor-alpha inhibits the injurious effects of adiponectin in rat steatotic liver undergoing ischemia-reperfusion. Hepatology (2008) 0.89
Exercise blood pressure, cardiac structure, and diastolic function in young normotensive patients with polycystic kidney disease: a prehypertensive state. Am J Kidney Dis (2004) 0.89
Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers. Hepatology (2003) 0.88
Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation. Liver Transpl (2010) 0.87
Prevention of I/R injury in fatty livers by ischemic preconditioning is associated with increased mitochondrial tolerance: the key role of ATPsynthase and mitochondrial permeability transition. Transpl Int (2009) 0.87
FDG PET imaging of Ela1-myc mice reveals major biological differences between pancreatic acinar and ductal tumours. Eur J Nucl Med Mol Imaging (2009) 0.86
Proteasome inhibitors protect the steatotic and non-steatotic liver graft against cold ischemia reperfusion injury. Exp Mol Pathol (2013) 0.86
Trimetazidine: is it a promising drug for use in steatotic grafts? World J Gastroenterol (2006) 0.86
How to protect liver graft with nitric oxide. World J Gastroenterol (2011) 0.85
Silent information regulator 1 protects the liver against ischemia-reperfusion injury: implications in steatotic liver ischemic preconditioning. Transpl Int (2014) 0.85
Insulin like growth factor-1 increases fatty liver preservation in IGL-1 solution. World J Gastroenterol (2010) 0.84
The future of fatty livers. J Hepatol (2004) 0.84
Bortezomib enhances fatty liver preservation in Institut George Lopez-1 solution through adenosine monophosphate activated protein kinase and Akt/mTOR pathways. J Pharm Pharmacol (2013) 0.83
Inhibition of angiotensin II action protects rat steatotic livers against ischemia-reperfusion injury. Crit Care Med (2008) 0.83
Effect of angiotensin II and bradykinin inhibition in rat reduced-size liver transplantation. Liver Transpl (2009) 0.82
The Association between Parathyroid Hormone Levels and Hemoglobin in Diabetic and Nondiabetic Participants in the National Kidney Foundation's Kidney Early Evaluation Program. Cardiorenal Med (2013) 0.82
Ubiquitin-proteasome system inhibitors and AMPK regulation in hepatic cold ischaemia and reperfusion injury: possible mechanisms. Clin Sci (Lond) (2012) 0.81
Effects of trimetazidine on the Akt/eNOS signaling pathway and oxidative stress in an in vivo rat model of renal ischemia-reperfusion. Ren Fail (2014) 0.81
The effects of glucose and lipids in steatotic and non-steatotic livers in conditions of partial hepatectomy under ischaemia-reperfusion. Liver Int (2013) 0.81
Up regulation of IL-6 by ischemic preconditioning in normal and fatty rat livers: association with reduction of oxidative stress. Free Radic Res (2006) 0.80
Melatonin prolongs graft survival of pancreas allotransplants in pigs. J Pineal Res (2011) 0.80
Streptozotocin-pancreatic damage in the rat: modulatory effect of 15-deoxy delta12,14-prostaglandin j(2) on nitridergic and prostanoid pathway. Nitric Oxide (2002) 0.80
Insulin-like growth factor and epidermal growth factor treatment: new approaches to protecting steatotic livers against ischemia-reperfusion injury. Endocrinology (2009) 0.80
Improved rat steatotic and nonsteatotic liver preservation by the addition of epidermal growth factor and insulin-like growth factor-I to University of Wisconsin solution. Liver Transpl (2010) 0.80
Cyclic adenosine 3',5'-monophosphate in rat steatotic liver transplantation. Liver Transpl (2011) 0.80
Adiponectin and resistin protect steatotic livers undergoing transplantation. J Hepatol (2013) 0.80
Simvastatin maintains function and viability of steatotic rat livers procured for transplantation. J Hepatol (2013) 0.79
Infection of metallothionein 1+2 knockout mice with Rocky Mountain Laboratory scrapie. Brain Res (2008) 0.79
Does adiponectin benefit steatotic liver transplantation? Liver Transpl (2011) 0.79
Mediators of rat ischemic hepatic preconditioning after cold preservation identified by microarray analysis. Liver Transpl (2006) 0.79
Retinol-binding protein 4 and peroxisome proliferator-activated receptor-γ in steatotic liver transplantation. J Pharmacol Exp Ther (2011) 0.78
Effects of pentoxifylline on intestinal bacterial overgrowth, bacterial translocation and spontaneous bacterial peritonitis in cirrhotic rats with ascites. Dig Liver Dis (2011) 0.78
Evaluation of Institut Georges Lopez-1 preservation solution in pig pancreas transplantation: a pilot study. Transplantation (2014) 0.76
The use of a reversible proteasome inhibitor in a model of Reduced-Size Orthotopic Liver transplantation in rats. Exp Mol Pathol (2012) 0.76
[Evaluation of IGL-1, a new organ preservation solution: preclinical results in renal transplantation]. Prog Urol (2005) 0.76
Role of oxidative stress in cardiovascular effects of anemia treatment with erythropoietin in predialysis patients with chronic kidney disease. Clin Nephrol (2012) 0.76
Retinol binding protein 4 and retinol in steatotic and nonsteatotic rat livers in the setting of partial hepatectomy under ischemia/reperfusion. Liver Transpl (2012) 0.76
AMP-activated protein kinase as a target for preconditioning in transplantation medicine. Transplantation (2010) 0.75
Correction: Carbonic Anhydrase Protects Fatty Liver Grafts against Ischemic Reperfusion Damage. PLoS One (2015) 0.75
Isoform-specific quantification of endothelins in HUVEC culture supernatants by on-line high-performance liquid chromatography/electrospray mass spectrometry. Biomed Chromatogr (2004) 0.75
[Ischemic preconditioning of the liver: from molecular bases to clinical application]. Cir Esp (2006) 0.75
[MORS--the stationary model centre of sociopsychiatric rehabilitation for youths--the program and evaluation]. Psychiatr Pol (2011) 0.75